Skip to main content

Table 4 Multivariate analysis

From: Tumor-B-cell interactions promote isotype switching to an immunosuppressive IgG4 antibody response through upregulation of IL-10 in triple negative breast cancers

 

Sig

HR

95% CI for HR

Recurrence free survival

 Race

0.791

1.095

0.560–2.140

 Grade

0.34

1.128

0.881–1.445

 Stage

0.000

1.442

1.247–1.667

 CD20 score

0.231

0.72

0.420–1.236

 IgG4

0.001

3.336

1.607–7.0560

 IL-10

0.000

7.195

2.418–21.411

 IL-4

0.279

1.535

0.707–3.337

Overall survival

 Race

0.604

0.83

0.411–1.678

 Grade

0.931

1.014

0.736–1.398

 Stage

0.000

1.329

1.151–1.534

 CD20 score

0.211

0.706

0.409–1.218

 IgG4

0.074

2.541

1.204–5.336

 IL-10

0.005

4.101

1.538–10.934

 IL-4

0.528

1.283

0.592–2.779

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us